TP53 and acute myeloid leukemia: Based on the observed G2/M arrest, as well as our prior observation that TP-0903 inhibits Chk kinases in other AML cell types, we anticipated that TP-0903 would induce a DNA damage response in TP53 mutant AML cell lines.